Bank of Montreal and Toronto-Dominion Bank remain central to Canada's financial landscape, yet their profiles differ in ways that matter for investors. BMO has emphasized capital markets and its larger U.S. footprint after the Bank of the West deal, while TD works through extended U.S. regulatory remediation even as it protects its strong domestic retail base. The contrast offers useful signals for those evaluating Canadian banks with cross-border exposure, especially amid easing credit conditions and evolving trade policies.
Founded in 1817, Bank of Montreal operates in personal and commercial banking, wealth management, and capital markets on both sides of the border. Shares have recently traded near the high end of the 52-week range, supported by a year-to-date total return near 34% and a one-year return around 37%. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry. Fiscal third-quarter adjusted EPS rose about 23% year over year, with adjusted ROE near 14% and closing in on the 15% medium-term goal. Capital markets drove much of the strength through higher equities trading and corporate banking revenue. The bank has outlined plans to simplify its portfolio, including the sale of its Transportation and Vendor Finance businesses and a new share repurchase program. Credit quality has stabilized, with lower provisions and fewer impaired loans. Analysts generally rate the shares Hold, noting that valuation looks full after the recent advance.
Established in 1855, Toronto-Dominion Bank ranks as Canada's second-largest by assets, with more than half its revenue from its leading domestic personal and commercial franchise plus a sizable U.S. retail network. TD has posted the stronger recent returns, with year-to-date gains near 36% and a one-year total return above 57%. Fiscal third-quarter adjusted EPS climbed to roughly C$2.74 from C$1.89, lifting net income about 39%. Adjusted ROE approached 16%, and the CET1 ratio stood near 14.3%. Results reflected broad momentum, including record Canadian banking figures and a rebound in U.S. retail. The bank still operates under a U.S. asset cap while funding AML remediation, though it plans roughly 100 new U.S. branches by 2028. Management continues to highlight cost discipline and AI-driven efficiencies.
Both institutions run diversified North American operations, yet their drivers and risks vary. BMO has shifted capital toward capital markets and its expanded U.S. presence, increasing sensitivity to trading volumes. TD relies more on stable domestic retail and wealth management, though its U.S. expansion remains limited by the asset cap during remediation. Over the trailing year, TD has outperformed, though its forward P/E sits comparable to BMO's while carrying a lower beta of about 0.87 versus 1.12. On capital, TD holds the higher CET1 ratio near 14.3% against BMO's 13%, providing more room for buybacks and dividends. Key risks include regulatory execution for TD and greater cyclical exposure for BMO. Both face pressure from Canadian mortgage renewals and trade-policy shifts.
From the data points available, Tickeron's AI would likely lean toward TD at present, citing its stronger trailing performance, higher capital buffer, broader segment momentum, and more stable revenue base. The consistency of its recovery from earlier regulatory pressure points to durable positioning despite the asset cap. At the same time, BMO's capital-markets gains and improving ROE make it an attractive option when trading conditions stay supportive. The view remains probabilistic, as relative standing could change with shifts in credit trends, capital-markets activity, or regulatory outcomes.
When evaluating pairs like these, I often turn to Tickeron's Trending AI Robots to see how systematic strategies are currently positioned across similar names. The platform surfaces a focused selection of bots whose recent performance and approach align with prevailing conditions, helping me cross-check momentum signals without replacing my own analysis.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The 10-day moving average for BMO crossed bearishly below the 50-day moving average on November 20, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 62%.
The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BMO as a result. In 36 of 66 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 55%.
The Moving Average Convergence Divergence Histogram (MACD) for BMO turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 24 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 52%.
BMO moved below its 50-day moving average on November 17, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 55%.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +2.18% 3-day Advance, the price is estimated to grow further. Considering data from situations where BMO advanced for three days, in 206 of 384 cases, the price rose further within the following month. The odds of a continued upward trend are 54%.
BMO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 153 of 328 cases where BMO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 47%.
The Tickeron SMR rating for this company is 3 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 39 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 26, placing this stock slightly worse than average.
The Tickeron Price Growth Rating for this company is 48 (best 1 - 100 worst), indicating steady price growth. BMO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 57 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 66 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.400) is normal, around the industry mean (1.500). P/E Ratio (13.902) is within average values for comparable stocks, (11.703). Projected Growth (PEG Ratio) (1.518) is also within normal values, averaging (2.139). Dividend Yield (0.029) settles around the average of (0.035) among similar stocks. P/S Ratio (4.411) is also within normal values, averaging (3.867).
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a major bank
Industry MajorBanks